info@marketresearchfuture.com   ๐Ÿ“ž +1 (855) 661-4441(US)   ๐Ÿ“ž +44 1720 412 167(UK)   ๐Ÿ“ž +91 2269738890(APAC)
Certified Global Research Member
Isomar 1 Iso 1
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major playersโ€™ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

COVID-19 Diagnostics Market Research Report By Test Type (PCR Tests, Antigen Tests, Antibody Tests, CRISPR Tests), By End User (Hospitals, Clinics, Laboratories, Home Care), By Sample Type (Nasopharyngeal Swabs, Oropharyngeal Swabs, Saliva, Serum), By Distribution Channel (Direct Sales, Retail Pharmacies, Online Sales) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035


ID: MRFR/HC/8232-CR | 119 Pages | Author: Rahul Gotadki| February 2021

Research Methodology on Covid-19 Diagnostics Market


Objective of the Study:


The primary objective of the proposed study is to analyze the market potential of Covid-19 diagnostics and strategies adopted by industry participants to capitalize on the same. Additionally, the study also aims to evaluate the overall awareness, demand, and future market opportunities of Covid-19 diagnostics.


Research Design:


The research design adopted for this proposed research study is both qualitative and quantitative. Qualitative research methods are employed for understanding the behaviour and preferences of the target audience and to assess the overall awareness about Covid-19 diagnostics. On the other hand, quantitative research is undertaken to analyse the current market conditions, major industry players and the strategies adopted by them. The various sources from which the data is obtained include published reports, testimonials, web resources, interviews with industry experts/operators, surveys, and other secondary sources of data.


Data Collection Process:


Primary Data Collection


The primary data for the study is mainly collected from surveys, questionnaires and interviews with the participants of the market like market players, and the end-users of the Covid-19 diagnostics. The primary data collection process is aimed at gaining permission to conduct surveys, reaching out to a sample set of customers and preparing questionnaires and opinion polls that could result in meaningful insights into the Covid-19 diagnostics market. The sample size in this study is obtained from individuals sourced by randomly selected populations and personal contacts.


Secondary Data Sources


The secondary data sources used in the research report include published reports, web resources, testimonials, surveys and other sources. The data provided on the website of the various market participants as well as various other research databases and other third-party sources are used for assessing the trend of the Covid-19 diagnostics market. The sources are mostly authentic, reliable, and credible.


Data Analysis


In the reporting phase of the research study, the data collected from primary and secondary sources are analyzed by employing the methods of quantitative and qualitative data analysis. Since the research is mainly concerned with understanding the market size, Porter's Five Forces Model is employed for analyzing the various factors that govern the market. The market is further analyzed by evaluating the trend of the major players in the market with the help of secondary data sources.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

1 EXECUTIVE SUMMARY

1.1 OVERVIEW 14

1.2 MARKET SYNOPSIS 14

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY 15

2.2 RESEARCH OBJECTIVE 15

3 RESEARCH METHODOLOGY

3.1 OVERVIEW 16

3.2 DATA MINING 16

3.3 SECONDARY RESEARCH 16

3.4 PRIMARY RESEARCH 18

3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 18

3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 19

3.5 FORECASTING METHODS 20

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 21

3.6.1 BOTTOM-UP APPROACH 21

3.6.2 TOP-DOWN APPROACH 22

3.7 DATA TRIANGULATION 22

3.8 VALIDATION 22

3.9 ASSUMPTIONS AND LIMITATIONS 23

3.9.1 ASSUMPTIONS AND LIMITATIONS 23

3.9.2 MARKET FACTORS 23

4 MARKET DYNAMICS

4.1 OVERVIEW 25

4.2 DRIVERS 26

4.2.1 INCREASING NUMBER OF COVID-19 CASES 26

4.2.2 GOVERNMENT AND PRIVATE FUNDS AS WELL AS SUPPORT FOR RESEARCH & DEVELOPMENT 26

4.2.3 RISING NUMBER OF EMERGENCY USE AUTHORIZATIONS (EUA) FOR DIAGNOSTIC KITS AND DEVICES 26

4.2.4 DEVELOPMENTS AND SUPPORT BY NON-MEDICAL DEVICE/DIAGNOSTIC COMPANIES 27

4.3 RESTRAINTS 28

4.3.1 RESTRICTIONS ON EXPORT OF DIAGNOSTIC KITS 28

4.3.2 ACCURACY OF TEST RESULTS 28

4.4 OPPORTUNITIES 28

4.4.1 DEVELOPMENT OF QUICK, ACCURATE, AND AFFORDABLE TESTS 28

4.4.2 COLLABORATION OF MAJOR PLAYERS WITH SMALL PLAYERS 28

5 MARKET FACTOR ANALYSIS

5.1 PORTERโ€™S FIVE FORCES MODEL 29

5.1.1 THREAT OF NEW ENTRANTS 29

5.1.2 BARGAINING POWER OF SUPPLIERS 30

5.1.3 THREAT OF SUBSTITUTES 30

5.1.4 BARGAINING POWER OF BUYERS 30

5.1.5 INTENSITY OF RIVALRY 30

5.2 SUPPLY CHAIN ANALYSIS 31

5.2.1 R&D AND DESIGNING 32

5.2.2 MANUFACTURING 32

5.2.3 DISTRIBUTION 32

5.2.4 MARKETING & SALES 32

5.2.5 POST-SALES MONITORING 32

5.3 IMPACT OF COVID-19 ON SUPPLY OF DIAGNOSTIC DEVICES 32

6 COVID-19 DIAGNOSTICS MARKET, BY TYPE

6.1 OVERVIEW 33

6.2 MOLECULAR TESTS 34

6.3 SEROLOGY TESTS 36

7 COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY

7.1 OVERVIEW 38

7.2 RT-PCR 40

7.3 ISOTHERMAL AMPLIFICATION 40

7.4 CRISPR 41

7.5 ELISA 42

7.6 HYBRIDIZATION 43

7.7 OTHERS 43

8 COVID-19 DIAGNOSTICS MARKET, BY END USER

8.1 OVERVIEW 44

8.2 HOSPITALS 45

8.3 PUBLIC HEALTH LABS 46

8.4 PRIVATE OR COMMERCIAL LABS 47

9 GLOBAL COVID-19 DIAGNOSTICS MARKET, BY REGION

9.1 OVERVIEW 48

9.2 EUROPE 50

COVID-19 DIAGNOSTICS MARKET, BY TYPE

COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY

COVID-19 DIAGNOSTICS MARKET, BY END USER

9.2.1 WESTERN EUROPE 52

COVID-19 DIAGNOSTICS MARKET, BY TYPE

COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY

COVID-19 DIAGNOSTICS MARKET, BY END USER

9.2.1.1 GERMANY 53

COVID-19 DIAGNOSTICS MARKET, BY TYPE

COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY

COVID-19 DIAGNOSTICS MARKET, BY END USER

9.2.1.2 SPAIN 54

COVID-19 DIAGNOSTICS MARKET, BY TYPE

COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY

COVID-19 DIAGNOSTICS MARKET, BY END USER

9.2.1.3 ITALY 55

COVID-19 DIAGNOSTICS MARKET, BY TYPE

COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY

COVID-19 DIAGNOSTICS MARKET, BY END USER

9.2.1.4 UK 56

COVID-19 DIAGNOSTICS MARKET, BY TYPE

COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY

COVID-19 DIAGNOSTICS MARKET, BY END USER

9.2.1.5 FRANCE 57

COVID-19 DIAGNOSTICS MARKET, BY TYPE

COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY

COVID-19 DIAGNOSTICS MARKET, BY END USER

9.2.1.6 REST OF WESTERN EUROPE 58

COVID-19 DIAGNOSTICS MARKET, BY TYPE

COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY

COVID-19 DIAGNOSTICS MARKET, BY END USER

9.2.2 EASTERN EUROPE 59

COVID-19 DIAGNOSTICS MARKET, BY TYPE

COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY

COVID-19 DIAGNOSTICS MARKET, BY END USER

9.3 AMERICAS 61

COVID-19 DIAGNOSTICS MARKET, BY TYPE

COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY

COVID-19 DIAGNOSTICS MARKET, BY END USER

9.3.1 NORTH AMERICA 63

COVID-19 DIAGNOSTICS MARKET, BY TYPE

COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY

COVID-19 DIAGNOSTICS MARKET, BY END USER

9.3.1.1 US 64

COVID-19 DIAGNOSTICS MARKET, BY TYPE

COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY

COVID-19 DIAGNOSTICS MARKET, BY END USER

9.3.1.2 CANADA 65

COVID-19 DIAGNOSTICS MARKET, BY TYPE

COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY

COVID-19 DIAGNOSTICS MARKET, BY END USER

9.3.2 LATIN AMERICA 66

COVID-19 DIAGNOSTICS MARKET, BY TYPE

COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY

COVID-19 DIAGNOSTICS MARKET, BY END USER

9.4 ASIA-PACIFIC 68

COVID-19 DIAGNOSTICS MARKET, BY TYPE

COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY

COVID-19 DIAGNOSTICS MARKET, BY END USER

9.4.1 INDIA 70

COVID-19 DIAGNOSTICS MARKET, BY TYPE

COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY

COVID-19 DIAGNOSTICS MARKET, BY END USER

9.4.2 AUSTRALIA 71

COVID-19 DIAGNOSTICS MARKET, BY TYPE

COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY

COVID-19 DIAGNOSTICS MARKET, BY END USER

9.4.3 SOUTH KOREA 72

COVID-19 DIAGNOSTICS MARKET, BY TYPE

COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY

COVID-19 DIAGNOSTICS MARKET, BY END USER

9.4.4 JAPAN 73

COVID-19 DIAGNOSTICS MARKET, BY TYPE

COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY

COVID-19 DIAGNOSTICS MARKET, BY END USER

9.4.5 CHINA 74

COVID-19 DIAGNOSTICS MARKET, BY TYPE

COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY

COVID-19 DIAGNOSTICS MARKET, BY END USER

9.4.6 REST OF ASIA-PACIFIC 75

COVID-19 DIAGNOSTICS MARKET, BY TYPE

COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY

COVID-19 DIAGNOSTICS MARKET, BY END USER

9.5 MIDDLE EAST & AFRICA 77

COVID-19 DIAGNOSTICS MARKET, BY TYPE

COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY

COVID-19 DIAGNOSTICS MARKET, BY END USER

9.5.1 MIDDLE EAST 79

COVID-19 DIAGNOSTICS MARKET, BY TYPE

COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY

COVID-19 DIAGNOSTICS MARKET, BY END USER

9.5.2 AFRICA 80

COVID-19 DIAGNOSTICS MARKET, BY TYPE

COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY

COVID-19 DIAGNOSTICS MARKET, BY END USER

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW 81

10.2 MAJOR PLAYERS IN THE GLOBAL COVID-19 DIAGNOSTICS MARKET 81

10.3 GLOBAL COVID-19 DIAGNOSTICS MARKET INSIGHTS 82

10.4 COMPETITIVE BENCHMARKING 83

10.5 COMPETITOR DASHBOARD 84

10.6 MAJOR GROWTH STRATEGIES IN THE GLOBAL COVID-19 DIAGNOSTICS MARKET 85

10.7 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL COVID-19 DIAGNOSTICS MARKET 86

10.8 KEY DEVELOPMENTS & GROWTH STRATEGIES 86

10.8.1 PRODUCT LAUNCHES 87

10.8.2 ACQUISITIONS 88

10.8.3 CONTRACTS 88

11 COMPANY PROFILES

11.1 BECTON, DICKINSON AND COMPANY 89

11.1.1 COMPANY OVERVIEW 89

11.1.2 FINANCIAL OVERVIEW 90

11.1.3 PRODUCTS/SERVICES OFFERED 90

11.1.4 KEY DEVELOPMENTS 91

11.1.5 SWOT ANALYSIS 91

11.1.6 KEY STRATEGIES 91

11.2 BIO-RAD LABORATORIES, INC. 92

11.2.1 COMPANY OVERVIEW 92

11.2.2 FINANCIAL OVERVIEW 92

11.2.3 PRODUCTS/SERVICES OFFERED 93

11.2.4 KEY DEVELOPMENTS 93

11.2.5 SWOT ANALYSIS 94

11.2.6 KEY STRATEGIES 94

11.3 DANAHER CORPORATION 95

11.3.1 COMPANY OVERVIEW 95

11.3.2 FINANCIAL OVERVIEW 96

11.3.3 PRODUCTS/SERVICES OFFERED 96

11.3.4 KEY DEVELOPMENTS 97

11.3.5 SWOT ANALYSIS 97

11.3.6 KEY STRATEGIES 97

11.4 ABBOTT 98

11.4.1 COMPANY OVERVIEW 98

11.4.2 FINANCIAL OVERVIEW 99

11.4.3 PRODUCTS/SERVICES OFFERED 99

11.4.4 KEY DEVELOPMENTS 100

11.4.5 SWOT ANALYSIS 100

11.4.6 KEY STRATEGIES 100

11.5 F. HOFFMANN-LA ROCHE LTD 101

11.5.1 COMPANY OVERVIEW 101

11.5.2 FINANCIAL OVERVIEW 102

11.5.3 PRODUCTS/SERVICES OFFERED 102

11.5.4 KEY DEVELOPMENTS 103

11.5.5 SWOT ANALYSIS 103

11.5.6 KEY STRATEGIES 103

11.6 BIOMร‰RIEUX SA 104

11.6.1 COMPANY OVERVIEW 104

11.6.2 FINANCIAL OVERVIEW 104

11.6.3 PRODUCTS/SERVICES OFFERED 105

11.6.4 PRODUCTS/SERVICES PIPELINE 105

11.6.5 KEY DEVELOPMENTS 105

11.6.6 SWOT ANALYSIS 106

11.6.7 KEY STRATEGIES 106

11.7 GENMARK DIAGNOSTICS, INC. 107

11.7.1 COMPANY OVERVIEW 107

11.7.2 FINANCIAL OVERVIEW 107

11.7.3 PRODUCTS/SERVICES OFFERED 108

11.7.4 KEY DEVELOPMENTS 108

11.7.5 SWOT ANALYSIS 108

11.7.6 KEY STRATEGIES 108

11.8 THERMO FISHER SCIENTIFIC INC. 109

11.8.1 COMPANY OVERVIEW 109

11.8.2 FINANCIAL OVERVIEW 109

11.8.3 PRODUCTS/SERVICES OFFERED 110

11.8.4 KEY DEVELOPMENTS 110

11.8.5 SWOT ANALYSIS 110

11.8.6 KEY STRATEGIES 111

11.9 QIAGEN 112

11.9.1 COMPANY OVERVIEW 112

11.9.2 FINANCIAL OVERVIEW 113

11.9.3 PRODUCTS/SERVICES OFFERED 113

11.9.4 KEY DEVELOPMENTS 114

11.9.5 SWOT ANALYSIS 114

11.9.6 KEY STRATEGIES 114

11.10 SIEMENS AG 115

11.10.1 COMPANY OVERVIEW 115

11.10.2 FINANCIAL OVERVIEW 115

11.10.3 PRODUCTS/SERVICES OFFERED 116

11.10.4 KEY DEVELOPMENTS 116

11.10.5 SWOT ANALYSIS 116

11.10.6 KEY STRATEGIES 117

12 APPENDIX

12.1 REFERENCES 118

12.2 RELATED REPORTS 119

13 LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS AND LIMITATIONS 23

TABLE 2 NUMBER OF NEW CASES IN COUNTRIES THAT ARE MOST AFFECTED BY COVID-19 AS OF 18 MAY 2022 26

TABLE 3 DEVELOPMENTS BY PHARMACEUTICAL COMPANIES TO BOOST THE TESTING OF COVID-19 27

TABLE 4 GLOBAL COVID-19 DIAGNOSTICS MARKET, BY TYPE, 2022-2030 (USD MILLION) 34

TABLE 5 US FOOD AND DRUG ADMINISTRATION (FDA) REVISED POLICY FOR CORONAVIRUS DISEASE-2019 MOLECULAR TESTS DURING THE PUBLIC HEALTH EMERGENCY 35

TABLE 6 GLOBAL COVID-19 DIAGNOSTICS MARKET, FOR MOLECULAR TESTS, BY REGION, 2022-2030 (USD MILLION) 35

TABLE 7 US FOOD AND DRUG ADMINISTRATION (FDA) REVISED POLICY FOR CORONAVIRUS DISEASE-2019 SEROLOGICAL TESTS DURING THE PUBLIC HEALTH EMERGENCY 36

TABLE 8 GLOBAL COVID-19 DIAGNOSTICS MARKET, FOR SEROLOGY TESTS, BY REGION, 2022-2030 (USD MILLION) 37

TABLE 9 GLOBAL COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 39

TABLE 10 GLOBAL COVID-19 DIAGNOSTICS MARKET, FOR RT-PCR, BY REGION, 2022-2030 (USD MILLION) 40

TABLE 11 US FOOD AND DRUG ADMINISTRATION (FDA) REVISED POLICY FOR CORONAVIRUS DISEASE-2019 DURING THE PUBLIC HEALTH EMERGENCY: USING ISOTHERMAL AMPLIFICATION TECHNOLOGY 41

TABLE 12 GLOBAL COVID-19 DIAGNOSTICS MARKET, FOR ISOTHERMAL AMPLIFICATION, BY REGION, 2022-2030 (USD MILLION) 41

TABLE 13 GLOBAL COVID-19 DIAGNOSTICS MARKET, FOR CRISPR, BY REGION, 2022-2030 (USD MILLION) 42

TABLE 14 US FOOD AND DRUG ADMINISTRATION (FDA) REVISED POLICY FOR CORONAVIRUS DISEASE-2019 DURING THE PUBLIC HEALTH EMERGENCY: USING ELISA 42

TABLE 15 GLOBAL COVID-19 DIAGNOSTICS MARKET, FOR ELISA, BY REGION, 2022-2030 (USD MILLION) 43

TABLE 16 GLOBAL COVID-19 DIAGNOSTICS MARKET, FOR HYBRIDIZATION, BY REGION, 2022-2030 (USD MILLION) 43

TABLE 17 GLOBAL COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022-2030 (USD MILLION) 45

TABLE 18 GLOBAL COVID-19 DIAGNOSTICS MARKET, FOR HOSPITALS, BY REGION, 2022-2030 (USD MILLION) 46

TABLE 19 GLOBAL COVID-19 DIAGNOSTICS MARKET, FOR PUBLIC HEALTH LABS, BY REGION, 2022-2030 (USD MILLION) 46

TABLE 20 GLOBAL COVID-19 DIAGNOSTICS MARKET, FOR PRIVATE OR COMMERCIAL LABS, BY REGION, 2022-2030 (USD MILLION) 47

TABLE 21 GLOBAL COVID-19 DIAGNOSTICS MARKET, BY REGION, 2022-2030 (USD MILLION) 49

TABLE 22 EUROPE: COVID-19 DIAGNOSTICS MARKET, BY REGION, 2022-2030 (USD MILLION) 50

TABLE 23 EUROPE: COVID-19 DIAGNOSTICS MARKET, BY TYPE, 2022-2030 (USD MILLION) 51

TABLE 24 EUROPE: COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 51

TABLE 25 EUROPE: COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022-2030 (USD MILLION) 51

TABLE 26 WESTERN EUROPE: COVID-19 DIAGNOSTICS MARKET, BY TYPE, 2022-2030 (USD MILLION) 52

TABLE 27 WESTERN EUROPE: COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 52

TABLE 28 WESTERN EUROPE: COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022-2030 (USD MILLION) 53

TABLE 29 GERMANY: COVID-19 DIAGNOSTICS MARKET, BY TYPE, 2022-2030 (USD MILLION) 53

TABLE 30 GERMANY: COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 53

TABLE 31 GERMANY: COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022-2030 (USD MILLION) 54

TABLE 32 SPAIN: COVID-19 DIAGNOSTICS MARKET, BY TYPE, 2022-2030 (USD MILLION) 54

TABLE 33 SPAIN: COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 54

TABLE 34 SPAIN: COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022-2030 (USD MILLION) 55

TABLE 35 ITALY: COVID-19 DIAGNOSTICS MARKET, BY TYPE, 2022-2030 (USD MILLION) 55

TABLE 36 ITALY: COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 55

TABLE 37 ITALY: COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022-2030 (USD MILLION) 56

TABLE 38 UK: COVID-19 DIAGNOSTICS MARKET, BY TYPE, 2022-2030 (USD MILLION) 56

TABLE 39 UK: COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 56

TABLE 40 UK: COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022-2030 (USD MILLION) 57

TABLE 41 FRANCE: COVID-19 DIAGNOSTICS MARKET, BY TYPE, 2022-2030 (USD MILLION) 57

TABLE 42 FRANCE: COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 57

TABLE 43 FRANCE: COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022-2030 (USD MILLION) 58

TABLE 44 REST OF WEST

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
report-img